Retigabine-d4 N-β-D-Glucuronide

• 产品号: R189062
• 分子式: C22H26FN3O8
• 分子量: 479.4555432

产品别名

• 标题: Retigabine-d4 N-β-D-Glucuronide
• IUPAC标准名: (2S,3S,4S,5R,6R)-6-({2-[(ethoxycarbonyl)amino]-5-({[4-fluoro(^2H₄)phenyl]methyl}amino)phenyl}amino)-3,4,5-trihydroxyoxane-2-carboxylic acid
• IUPAC传统名: (2S,3S,4S,5R,6R)-6-({2-[(ethoxycarbonyl)amino]-5-({[4-fluoro(^2H₄)phenyl]methyl}amino)phenyl}amino)-3,4,5-trihydroxyoxane-2-carboxylic acid
• 别名: 1-Deoxy-1-[[2-[(ethoxycarbonyl)amino]-5-[[(4-fluorophenyl)methyl]amino]pheny-d4l]amino] β-D-Glucopyranuronic Acid

产品详细信息

详细说明 (English)

Labelled Retigabine N-β-D-Glucuronide, the major metabolite of the antiepileptic drug Retigabine (R189050) that is produced via N-glucuronidation in humans.

参考文献

• Hiller, A. et al.: Drug Metab. Dispos., 27, 605 (1999)
• Borlak, J. et al.: Metab. Clin. Exp., 55, 711 (1999)
• McNeilly, P.P. et al.: Zenobiotica, 27, 431 (1999)